Valuation: Becton, Dickinson and Company

Market Cap 49.85B 43.56B 40.94B 37.36B 70.12B 4,765B 70.13B 491B 190B 2,433B 187B 183B 7,845B P/E 2026 *
35.3x
P/E 2027 * 19.7x
Enterprise Value 65.73B 57.44B 53.99B 49.27B 92.47B 6,284B 92.48B 648B 250B 3,209B 247B 241B 10,345B EV / Sales 2026 *
3.41x
EV / Sales 2027 * 3.23x
Free-Float
73.18%
Yield 2026 *
2.14%
Yield 2027 * 2.18%
1 day-1.25%
1 week-1.47%
Current month-3.14%
1 month-6.69%
3 months+25.35%
6 months+16.67%
Current year-5.35%
1 week 157.2
Extreme 157.2
159.5
1 month 151.3
Extreme 151.3
168.75
Current year 122.15
Extreme 122.15
179.95
1 year 122.15
Extreme 122.15
179.95
3 years 122.15
Extreme 122.15
253.5
5 years 122.15
Extreme 122.15
265.45
10 years 122.15
Extreme 122.15
265.45
Manager TitleAgeSince
Chief Executive Officer 53 2020-01-27
Director of Finance/CFO 44 2025-12-04
Compliance Officer - 2023-01-31
Director TitleAgeSince
Director/Board Member 75 2002-09-23
Director/Board Member 71 2010-07-25
Chairman 53 2021-04-27
Change 5-day change 1-year change 3-year change Capi.($)
-1.25%-1.47% - - 49.22B
+0.69%+1.63%-24.10%+5.64% 178B
-1.07%-3.18%-4.07%+13.08% 117B
-0.65%-2.74%+8.88%+69.09% 60.39B
+1.27%-1.57%-1.90%-31.00% 49.22B
-0.22%+1.23%+7.80%+45.79% 48.02B
+0.40%+3.56%+28.80%+2.32% 33.65B
+7.73%+7.23% - - 28.04B
+2.57%+1.67%+47.13%-0.38% 25.46B
+2.38%+8.63%+11.66%-10.18% 22.5B
Average +1.19%+1.67%+9.27%+11.80% 62.54B
Weighted average by Cap. +0.49%+0.39%-2.85%+13.51%

Financials

2026 *2027 *
Net sales 19.26B 16.83B 15.82B 14.44B 27.09B 1,841B 27.1B 190B 73.26B 940B 72.33B 70.75B 3,031B 19.73B 17.24B 16.21B 14.79B 27.76B 1,886B 27.76B 195B 75.06B 963B 74.11B 72.48B 3,106B
Net income 1.44B 1.26B 1.18B 1.08B 2.02B 137B 2.02B 14.16B 5.46B 70.14B 5.4B 5.28B 226B 2.34B 2.04B 1.92B 1.75B 3.29B 224B 3.29B 23.06B 8.9B 114B 8.79B 8.59B 368B
Net Debt 15.88B 13.88B 13.05B 11.91B 22.35B 1,519B 22.35B 157B 60.42B 775B 59.65B 58.35B 2,500B 13.95B 12.19B 11.46B 10.46B 19.63B 1,334B 19.63B 138B 53.07B 681B 52.39B 51.25B 2,196B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
26-09-22 €158.85 +1.05% 10
26-09-21 €157.20 -0.19% 57
26-09-18 €157.50 -1.25% 4
26-09-17 €159.50 -0.84% 0
26-09-16 €160.85 +0.63% 0
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
183.00USD
Average target price
195.67USD
Spread / Average Target
+6.92%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!